Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 801–900 of 1,000
Stem Cells in Equine Veterinary Practice—Current Trends, Risks, and Perspectives
Kornicka, K., Geburek, F., Röcken, M., & Marycz, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050675 · Cited by 7
“Accordingly, the secretome of MSCs and the mechanisms by which it affects damaged tissues has been under intense investigation recently [44,45].”
BackgroundCarmona-Luque, M., Ballesteros-Ribelles, A., Millán-López, A., Blanco, A., Nogueras, S., & Herrera, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092480 · Cited by 6
“…their functional properties, such as expansion potential, immunophenotype, differentiation capacity, cytokine secretion ability, and senescence [18–20], in a single culture passage, and their results showed functional differences concerning their differentiation and proliferation capacities…”
BackgroundInnovative Strategies: Use of Stromal Cell-Derived Secretome for Chronic Wound Therapy
Ghetu, D.-M., Raymond, K., Titorencu, I. D., & Simionescu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125609 · Cited by 6
“Compared to cells, the cell-derived secretome has the advantages of being less immunogenic, having minimal risk of tumour formation [37,38], exhibiting enhanced safety, and being easier to handle [39].”
Xu, J., Chen, C., Gan, S., Liao, Y., Fu, R., Hou, C., Yang, S., Zheng, Z., & Chen, W. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-09027-7 · Cited by 6
Chen, W., Lai, W.-Y., Le, D., Hsing, J.-C., Ngo, M.-H. T., Kao, C.-X., Fan, K.-Y., Lin, G., Ling, T., Kuo, Y., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04688-6 · Cited by 6
“Compared with MSCs, MSC–CM can easily penetrate smaller wounds and exert lasting effects in vivo [14].”
Weng, X., Li, J., Guan, Q., Zhao, H., Wang, Z., Gleave, M. E., Nguan, C. Y. C., & Du, C. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113081 · Cited by 6
Isolation and characterization of feline endometrial mesenchymal stem cells
Park, M. K., & Song, K. (2024) · Journal of Veterinary Science · doi:10.4142/jvs.23267 · Cited by 6
The Omentum—A Forgotten Structure in Veterinary Surgery in Small Animals’ Surgery
Morawska-Kozłowska, M., Wilkosz, A., & Zhalniarovich, Y. (2024) · Animals · doi:10.3390/ani14131848 · Cited by 13
“These cells have demonstrated encouraging outcomes in early-stage investigations for various therapeutic uses, including repairing and renewing tissues [29,30].”
BackgroundCellular regenerative therapy in stress urinary incontinence: new frontiers?—a narrative review
Andersson, K., & Williams, J. K. (2024) · Translational Andrology and Urology · doi:10.21037/tau-22-682 · Cited by 6
“The mechanisms involved in e.g., immunomodulation, angiogenesis, inflammation, apoptosis, and tissue repair may be regulated by secretomes (8,9).”
InfluentialKato, Y., Aburakawa, D., Tashiro, R., Zhou, Y., Rashad, S., Endo, H., Tominaga, T., & Niizuma, K. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241290363 · Cited by 7
“9,10 Many clinical trials have failed to replicate the promising results of MSC treatment following ischemic stroke, 11–13 however, which may be due to the insufficient regenerative capacity of MSCs. Homing of transplanted stem cells to the injured tissues and differentiation of the transplanted…”
Dual-Double Stem Cell Ovarian Therapy: A Comprehensive Approach in Regenerative Medicine
Ljubić, A., Dinić, M., Švraka, D., & Vujović, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010069 · Cited by 7
Ababneh, N. A., AlDiqs, R., Nashwan, S., Ismail, M. A., Barham, R., Hadidi, S. A., Alrefae, A., Alhallaq, F., Abu-Humaidan, A. H. A., Saleh, T., et al. (2025) · Biomedical Reports · doi:10.3892/br.2025.1994 · Cited by 6
“However, several significant challenges limit their potential for therapeutic appli‑ cations, including their limited ability to expand efficiently (9).”
Progress and prospect of stem cell therapy for diabetic erectile dysfunction
Luo, D., Li, Y., Deng, Z.-Q., & Liu, G. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i12.2000 · Cited by 6
Torizal, F. G., Kerans, F. F. A., & Khumaira, A. (2022) · Biocell · doi:10.32604/biocell.2022.019591 · Cited by 8
Secretome as neuropathology-targeted intervention of Parkinson’s disease
Ardianto, C., Shen, R. K., Barus, J., Sasmita, P. K., Turana, Y., Lilis, L., & Sidharta, V. M. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.08.003 · Cited by 7
“Secretome anti-inflammatory effects are mediated by soluble immunoregulatory molecules, such as interleukin (IL)-13 and IL1 receptor antagonist (IL1RA), but they also contain proinflammatory cytokines such as IL1b [49].”
BackgroundInfluentialFurusaka, Y., Inoué, S., Mizoguchi, I., Hasegawa, H., Katahira, Y., Watanabe, A., Sakamoto, E., Sekine, A., Miyakawa, S., Umezu, T., et al. (2023) · Cancer Science · doi:10.1111/cas.15789 · Cited by 6
Ahmadi, F., Lotfi, A. S., Nigjeh, M. N., & Kadivar, M. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04532-8 · Cited by 6
“MSCs are favorable therapeutic candidates for a variety of disorders as they feature the following characteristics: (a) low immunogenicity [25], (b) expand in culture, (c) multilineage differentiation capacity [26], (d) secrete a wide range of trophic soluble molecules that have regenerative, immunomodulatory, anti-ap…”
BackgroundInfluentialTumor-targeted suicide gene-directed enzyme prodrug therapy mediated by extracellular vesicles
Jakubechova, J., Altanerova, U., & Altaner, Č. (2023) · Neoplasma · doi:10.4149/neo_2023_230328n172 · Cited by 6
Wang, L., Chio, C., Chao, C., Chao, P.-Y., Lin, M., Chang, C., & Lin, H. (2024) · Science Progress · doi:10.1177/00368504241231154 · Cited by 8
“37,38 In experimental TBI models, the secretome from BM-MSCs has been found to facilitate the repair of damaged brain tissue by supporting the survival and proliferation of neural stem cells.”
BackgroundKamal, D., Rady, D., Moshy, S. E., Radwan, I. A., Ahmed, N. E.-M. B., Wadan, A. S., Mehanny, S., & Eldin, L. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-15924-7 · Cited by 5
“The cell-free nature of secretome therapy inherently mitigates risks associated with live-cell transplantation as immunogenicity, tumorigenicity, and ethical concerns 13,55,56 positioning it as a regulatory-friendly alternative.”
Campo-Montoya, R. D., Piera, X. M. I., Romero-Murillo, S., Santamaría, E., Garbayo, E., & Blanco‐Prieto, M. J. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107368 · Cited by 7
Emerging cell-based and cell-free therapeutic strategies for vitiligo
Gholijani, N., Noori, E., Zarei‐Behjani, Z., Rezaee, D., Khodaei, M., Darya, G., Mehdinejadiani, K., & Dehghan, Z. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100331 · Cited by 5
“Stem cell secretomes, which encompass a diverse array of bioactive peptides, exhibit protective and reparative characteristics akin to those of their cellular counterparts [89].”
Cell-Free Therapies for Chronic Pain: The Rise of the Mesenchymal Stem Cell Secretome
Amodeo, G., Galimberti, G., Niada, S., Giannasi, C., Morte, E. D., Franchi, S., Riboldi, B., Ceruti, S., Brini, A. T., & Sacerdote, P. (2025) · Brain Sciences · doi:10.3390/brainsci15121263 · Cited by 6
“All these factors, which mediate most of the paracrine effects traditionally attributed to stem cell therapy, collectively influence pain-related signaling cascades, glial cell activation and peripheral and central sensitization mechanisms [33,35].”
InfluentialBridging Osteoimmunology and Regenerative Therapy: The Role of MSCs and Extracellular Vesicles
Álvarez-Iglesias, I., Colombo, A., Gil‐de‐Gómez, L., García‐Sánchez, D., González-González, A., & Pérez-Campo, F. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031155 · Cited by 7
The role of MSC-derived exosomes in immune modulation and regenerative medicine
Pandey, S. N., Afzal, M., Goyal, K., Rekha, M. M., Nayak, P. P., Maqbool, M., Khan, Y., Maji, C., Gupta, G., Alzarea, S. I., et al. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2620707 · Cited by 6
“Available data imply that the MSc-exo-based approach to therapy has several potential benefits, as compared to the cell-based ones, in terms of safety, efficacy, and the ability to customise cargoes carried by the delivery system [180,181].”
Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases
Long, X., Tan, D., Tao, Q., Ye, Q., Ye, L., Li, Q., & Xiao, J. (2026) · Cell Proliferation · doi:10.1111/cpr.70178 · Cited by 6
“These vesicles represent a safer and more versatile cell-free therapeutic alternative, circumventing limitations associated with stem cell therapy including embolism formation, aberrant differentiation, infection, infusion toxicity, immunogenicity, tumourigenicity and ethical concerns [209, 210].”
Akbarzadeh, A., Farrokhi, M. R., Firoozabadi, M. A., Mortazavi, S. J., Mortazavi, J. S., Vakili, S., Shapoori, S., & Jafarinia, M. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02047-0 · Cited by 5
Role of exosome therapy in reconstructive surgery: a review
Arkoubi, A. Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1697228 · Cited by 7
“In preclinical models, ADSC exosomes accelerate re-epithelialization and improve dermal architecture, making them highly relevant for scar modulation and chronic wound healing (26).”
Lespay‐Rebolledo, C., Tapia-Bustos, A., Pérez-Lobos, R., Vío, V., Casanova-Ortiz, E., Farfán-Troncoso, N., Zamorano-Cataldo, M., Redel, M., Ezquer, F. E., Quintanilla, M. E., et al. (2021) · Antioxidants · doi:10.3390/antiox11010074 · Cited by 5
Liang, T., Lu, L., Tang, S.-Y., Zheng, Z., Shi, K., & Liu, J. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i4.150 · Cited by 5
A bibliometric systematic review of extracellular vesicles in eye diseases from 2003 to 2022
Luo, X., Yan, X., Yin, D., Xia, Y., Li, S., shi, S., Gao, M., Yang, C., & Zhou, J. (2023) · Medicine · doi:10.1097/md.0000000000034831 · Cited by 5
“[27] Stem cell-derived EVs offer a new avenue for cell-free therapy in regenerative medicine, as they have effects similar to those of stem cells in tissue regeneration and can easily traverse biological barriers and enter target organs because of their nanometer size.[28,29] RGCs are essential for vision as they tran…”
BackgroundBruk, L. A., Fan, X., Resnick, J. L., & Fedorchak, M. V. (2023) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/2023/6039254 · Cited by 6
“Cell-free CM-based therapies ofer biological benefts and reduce safety concerns of stem cells while providing logistical advantages for clinical use, including scalability, availability, and longer shelf-life [17].”
Cuadra, B., Silva, V., Huang, Y.-L., Díaz, Y., Rivas, C., Molina, C., Simon, V., Bono, M. R., Morales, B., Rosemblatt, M. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042073 · Cited by 7
“…of individual factors, including PGED2, IDO, IL-10, and TSG-6, can partially reduce the in vitro and in vivo MSC effects, suggesting that the therapeutic effects of MSCs are mediated by the interaction of various factors that regulate the multiple signaling pathways of the immune system [43,48].”
BackgroundInfluentialWicaksono, S., Nur’aeny, N., Susanto, H., Nugraha, A. P., & Ernawati, D. S. (2024) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2024.07.006 · Cited by 7
Chiang, B., Mao, S.-H., Chen, T., Chung, S., & Chien, C. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.12.006 · Cited by 5
Sato, S., Teramura, Y., Ogawa, Y., Shimizu, E., Otake, M., Hori, K., Kamata, T., Shu, Y., Seta, Y., Kuramochi, A., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.03.002 · Cited by 5
“Recent studies suggest that the ben-e fi ts of these MSC therapies may arise from the various bioactive factors secreted from MSCs [15 e 17].”
Liu, Y., Xu, W., Liu, G., Ma, L., & Li, Z. (2025) · EFORT Open Reviews · doi:10.1530/eor-2024-0142 · Cited by 5
“In addition, as part of neuroprotection, mesenchymal stem cells secrete various neurotrophic factors, including BDNF, GDNF, NGF, NT-1 and NT-3 (8, 30).”
Ma, Y., Cao, L., Li, P. A., Jiao, Z., Liu, X., Lu, X., Liu, T., & Wang, H. (2025) · Cells · doi:10.3390/cells14100722 · Cited by 5
The role of stem cell-derived exosomes in regulating pyroptosis for disease therapy
Guo, Y., Liu, Q., Yang, J., Gao, Y. T., & Liu, Y. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04519-8 · Cited by 6
“…stem cell-derived exosomes (MSC-Exos) inherit therapeutic properties, including anti-inflammatory, tissue regeneration, and immunomodulation activities, that are comparable to those of stem cells used for therapy [52], demonstrating significant potential for treating various diseases [53–55].”
Jin, Y.-X., & Jin, G. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s547675 · Cited by 8
“27 Therefore, exosomes can not only serve as an alternative to stem cell therapy (by simulating its core paracrine effects) 26,32 but also act as an auxiliary means (used in combination with cell therapy to enhance efficacy and reduce safety risks).”
InfluentialHodge, J., Medina-Lopez, A., Neal, C. A., Decker, H. E., Robinson, J. L., & Mellott, A. J. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2572177 · Cited by 5
“…has inspired therapies that leverage the MSC secretome, which consists of a heterogenous collection of biomodulatory proteins ( e.g ., growth factors and cytokines), nucleic acids ( e.g ., microRNA), and small molecules ( e.g ., antioxidants), to target specific regenerative pathways [28,29].”
Hurtado, J. C., González, L. M., Ospina, L., Sperling, L. E., & Chaparro, O. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666211209155333 · Cited by 6
Li, W., Yang, Y., Zhang, X., Lin, Y., Li, H., Yao, Y., & Mu, D. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01329-7 · Cited by 5
García‐Sánchez, D., González-González, A., Álvarez-Iglesias, I., del Dujo-Gutiérrez, M., Bolado‐Carrancio, A., Certo, M., Pérez‐Núñez, M. I., Riancho, J. A., Rodríguez-Rey, J. C., Delgado‐Calle, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512399 · Cited by 5
“In view of this, researchers have focused their attention on the secretome of MSCs as a key tool for MSCs-mediated regenerative medicine [13].”
BackgroundSala, F. D., Longobardo, G., di Gennaro, M., Messina, F., & Borzacchiello, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133793 · Cited by 7
Zhu, Y., Liu, X., Chen, X., & Liao, Y. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03904-z · Cited by 9
“And it is recognized that various positive effects of MSCs are mainly attributed to their paracrine factors in vivo, like growth factors, anti-inflammatory cytokines, pro-angiogenic factors, anti-fibrotic factors inhibitor proteins of apoptosis, and nerve growth factors [25].”
BackgroundGaol, L. L., Purba, A., Diposarosa, R., & Pratiwi, Y. S. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s480061 · Cited by 6
“37,38 During normal conditions, HIF-1α will hydroxylate by the prolyl hydroxylase domain (PHD), leading to its degradation because of the interaction with von the Hippel−Lindau tumor suppressor protein (pVHL).”
BackgroundPreclinical Evidence for the Role of Stem/Stromal Cells in Targeting ARDS
Cruz, T., & Rojas, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29403-8_11 · Cited by 5
Eslami, A., Dehbashi, M., Ashja‐Arvan, M., Salehi, H., Azimzadeh, M., & Ganjalıkhani-Hakemi, M. (2020) · Cytotechnology · doi:10.1007/s10616-020-00421-8 · Cited by 5
Mahyudin, F., Yazid, H., Edward, M., Basuki, M. H., Bari, Y. A., & Rantam, F. (2020) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_52_20 · Cited by 6
“[13] Secretome application is also considered safer due to containing no cellular element that makes it is less possibility of mutation and transforms into cancer-associated fibroblast within cancer microenvironment.[14,15,16]”
BackgroundProteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
Lobov, A. A., Yudintceva, N. M., Mittenberg, A. G., Shabelnikov, S., Mikhailova, N., Malashicheva, A., & Георгиевич, Х. М. (2020) · Molecules · doi:10.3390/molecules25225283 · Cited by 5
“Despite described anti-apoptotic effect of hMSCs secretome, this functional cluster is not usually enriched in the hMSCs secretome [44].”
BackgroundStem cells in neonatal diseases: An overview
Chaubey, S., & Bhandari, V. (2022) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2022.101325 · Cited by 6
Zhang, X., Shi, W., Wang, X., Zou, Y., Wen, X., & Lu, N. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x19666230908142426 · Cited by 5
Immunomodulatory Properties of Dental-Derived Mesenchymal Stem Cells
Andrukhov, O., Behm, C., Blufstein, A., & Rausch‐Fan, X. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.78049 · Cited by 5
“This statement is supported by the observations that the secretome of MSCs exert similar tissue regenerative effects as transplanted MSCs [191].”
BackgroundIs Stem Cell Commerce in Small Animal Therapies Scientifically and Morally Justified?
Pinheiro, L. L., de Lima, A. R., & Branco, E. R. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09898-z · Cited by 7
Update on Mesenchymal and Induced Pluripotent Stem Cells
Al‐Anazi, K. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77857 · Cited by 5
Liu, X. Y. E., Park, E., Barretto, T. A., Liu, E., Ferrier, G. A., Tavakkoli, J., & BAKER, A. J. (2020) · Zebrafish · doi:10.1089/zeb.2020.1859 · Cited by 6
“53 The use of CM has advantages when compared with cell-based treatments because the evaluation for safety and pharmacokinetic properties is similar to conventional pharmaceutical agents.”
Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells
Cai, H., Wang, Z., Tang, W., Ke, X., & Zhao, E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970699 · Cited by 5
“In earlier studies, the efficacy of MSC therapy was primarily attributed to the ability of these cells to locally transplant and differentiate into multiple tissue types (Vizoso et al., 2017).”
BackgroundSafety and Efficacy of Mesenchymal Stem Cells in Burn Therapy: Systematic Review
Dini, T., Nugraha, Y., Revina, R., & Karina, K. (2022) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v6i3.252 · Cited by 5
El‐Mahalaway, A. M., El-Azab, N. E.-E., Abdrabbo, M., Said, O. M. S., Sabry, D., & Sibaie, M. M. E. (2018) · Journal of Gastrointestinal Cancer and Stromal Tumors · doi:10.4172/2157-7633.1000431 · Cited by 5
“It is accepted by many authors [51,55] that they may play an important role in the regulation of numerous physiological processes through promoting secretion of anti-inflammatory cytokines, decreasing angiogenesis by reduction of VEGF, immune activation, regenerative capacities, and cell plasticity.”
BackgroundAbdel-Mohsen, A. F., Salama, N. M., Rashed, L. A., Farag, E. A., & Hameed, A. A. (2018) · The Egyptian Journal of Histology · doi:10.21608/ejh.2018.29264 · Cited by 5
Ge, Y., & Wang, X. (2020) · doi:10.21203/rs.3.rs-37420/v1 · Cited by 5
Wang, S., Zhang, X., Wang, Y., Wang, S., & Li, L. (2024) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-024-00902-7 · Cited by 4
“Liu et al. demonstrated that caused by hypoxia and nutrient-limited environment in the damaged heart, limits their clinical application [ 22 ].”
Forty Years of the Use of Cells for Cartilage Regeneration: The Research Side
Roseti, L., Cavallo, C., Desando, G., D’Alessandro, M., & Grigolo, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121622 · Cited by 4
Eshraghi, N., Javidan, A., Al-Saeidi, N. N., Makuku, R., Mortezaei, A., & Mirghaderi, P. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00414-z · Cited by 5
“…whole MSC transplantation, exosome-based therapies offer significant advantages, including a lower risk of immune rejection, reduced tumorigenic potential, and simpler storage and handling requirements, making them a promising cell-free alternative for musculoskeletal regeneration (Table 1) [22].”
Sousa, P., Lopes, B., Sousa, A. C., Moreira, A. D. S., Rêma, A., Alvites, R., Geuna, S., Alves, N. M., & Maurício, A. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115081 · Cited by 5
“Moreover, secretome helps to modulate inflammation, accelerate angiogenesis and stimulate ECM remodeling, all of which contribute to faster wound closure and improved tissue quality [11–15].”
Zayed, M., & Jeong, B. (2025) · Cells · doi:10.3390/cells14110851 · Cited by 4
“Considering the numerous benefits of the MSC secretome [37], we hypothesized that the AdMSC secretome would ameliorate neuroin-flammation.”
Nishida, H., Matsuura, H., Yoshizaki, K., Sakaguchi, Y., Izawa, T., Sonoda, H., EDAMURA, K., & Tabata, Y. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.05.014 · Cited by 4
Tomaselli, A., Tripodi, M., Provitera, L., Raffaeli, G., Crippa, S., Raymo, L., Bronzoni, C. V., Santi, L., Arribas, C., Fumagalli, M., et al. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1624236 · Cited by 4
“A conditioned medium (CM) is a source of the secretome and vesicular elements used in regenerative therapies (210).”
InfluentialClinical Status of Exosomes: A Review
Sgaglione, J., Neufeld, E. V., Swami, P. N., & Grande, D. A. (2025) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1177/15563316251362179 · Cited by 10
“23,58 This research has revealed more defined and precise active subcellular “organelles,” structures that may be responsible for advancing morphogenic and paracrine functional pathways.”
Ye, K., Peng, Q., Zhang, Z.-G., Li, X., Xue, H.-B., Guo, H., Hei, H.-Y., & Wang, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115481 · Cited by 5
Functional impacts of lactylation in Hypoxia‒primed mesenchymal stromal cells
Zhao, F., Tang, Q., & Liu, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1678282 · Cited by 5
Rossello-Gelabert, M., Heras, K. L., Gonzalez‐Pujana, A., Igartua, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04775-8 · Cited by 6
“Strong evidence shows that the MSC-derived secretome can reproduce many of the therapeutic effects of the cells themselves [1, 14–16].”
Growth Factor-Primed WJ-MSC Secretome Enhances Fibroblast Expansion In Vitro
Jarquín-Yáñez, K., Aguilar-Sandoval, D. M., Piñón-Zárate, G., Herrera-Enríquez, M. Á., Avila-Campos, I. D., Hernández‐Téllez, B., Dominguez-Diaz, D. M., Blancas-Luciano, B. E., & Castell-Rodríguez, A. E. (2025) · Biomedicines · doi:10.3390/biomedicines13122863 · Cited by 5
Regenerative medicine approaches for treating diabetes: Current advances and future directions
Medenica, S., Abazović, D., Vuković, J., Vojinović, T., Tomović, F., Defeudis, G., Mazzilli, R., Kovačević, Z., Djurdjic, D., Prelević, V., et al. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109232 · Cited by 5
Exosomes from LPS-pretreated BMSCs treated periodontitis via improving oxidative stress
Xu, C., Wang, H., Dong, W., Cheng, W., Su, Y., Yang, Q., Wang, Y., & Zhao, Y. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04860-y · Cited by 4
“Previous studies have demonstrated that BMSCs-derived exosomes can promote periodontal tissue regeneration [24].”
Cetin, E. C., Alsoud, L. O., Mahi, Y. E., Park, H.-S., Mathyk, B. A., Omran, M. M., Salih, S. M., Al-Hendy, A., & Ali, F. L. (2026) · Human Reproduction · doi:10.1093/humrep/deag004 · Cited by 4
Orthobiologics: Current Evidence and What Lies Beyond the Horizon?
Chatha, P. K., Pellakuru, S. R., Botchu, R., Rajesh, S., Thakur, A., Chapala, S., Sarda, P., Jindal, M., & Sharma, G. K. (2026) · Seminars in Musculoskeletal Radiology · doi:10.1055/a-2724-9777 · Cited by 4
“27 They are also considered major contributors to the paracrine effects observed in MSC-based therapies.”
Ponnikorn, S., Thanasarnaksorn, W., Hongeng, S., Ratanapun, N., Phukhao, S., Sriwichai, P., & Suwanchinda, A. (2025) · Aesthetic Surgery Journal · doi:10.1093/asj/sjaf254 · Cited by 5
Pinto-Cardoso, R., Bessa-Andrês, C., Correia‐de‐Sá, P., & Noronha‐Matos, J. B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115646 · Cited by 5
Zhu, J., Zhao, F., Chai, Y., Jia, X., & Li, F. (2023) · Human Cell · doi:10.1007/s13577-023-01010-5 · Cited by 4
Hokmabadi, A., Ranjbar, E., Alipour, F., Ebrahimzadeh‐Bideskan, A., Afshari, J. T., Rezaei, M. M., & Shafieian, R. (2024) · Toxicology · doi:10.1016/j.tox.2024.153788 · Cited by 4
Prišlin, M., Butorac, A., Bertoša, R., Kunić, V., Ljolje, I., Kostešić, P., Vlahović, D., Naletilić, Š., Turk, N., & Brnić, D. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1387174 · Cited by 4
Rodrigues, G. M., de Almeida, M. E., Marcelino, S. A. C., Fernandes, P. B. U., da Cruz, J. O. P., Araújo, F. L., Ferreira, R. D. S., Botelho, A. F. M., Bedoya, F. J., Cahuana, G. M., et al. (2024) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2024-0004 · Cited by 4
“The secretome is a complex mixture of proteins, including growth factors, cytokines, and vesicular fractions, that have active pharmaceutical potential [30].”
BackgroundSousa, P., Lopes, B., Sousa, A. C., Coelho, A., Moreira, A. D. S., Rêma, A., Gonçalves-Maia, M., Amorim, I., Alvites, R., Alves, N. M., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122854 · Cited by 4
Secretome of the Olfactory Ensheathing Cells Influences the Behavior of Neural Stem Cells
Hsueh, Y.-H., Chen, K.-P., Buddhakosai, W., Le, P.-N., Hsiung, Y.-W., Tu, Y., Chen, W., Lu, H., & Tu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010281 · Cited by 4
Yang, J. H., Yuan, J., Wen, Y.-Q., Wu, L., Liao, J.-J., & Qi, H. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i1.98349 · Cited by 4
Phenotypic alterations in articulating joint cells: Role of mechanically loaded MSC secretome
Ladner, Y. D., Menzel, U., Thompson, K., Armiento, A. R., & Stoddart, M. J. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42234 · Cited by 5
“Insights into the chondro-regenerative potential of mechanically loaded MSC secretome could lead to the development of off-the-shelf, acellular therapeutic products with advantages in storage, handling, and shelf-life [61].”
Irfan, M., Kim, J., Sreekumar, S., & Chung, S. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1592599 · Cited by 4
Biodistribution studies of 89Zr-Labeled stem cell-derived exosomes using PET imaging
Li, J., Li, C., Zheng, H., Yaddanapudi, K., & Ng, C. K. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112000 · Cited by 4
Raimondi, L., Costa, V., Zappini, G., Piccinini, M., Scilabra, S. D., Pinto, M. L., Luca, A. D., Bellavia, D., Toscano, A., Bondi, A., et al. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214391 · Cited by 4
Secretome, Extracellular Vesicles, Exosomes
Jenner, F., & Ribitsch, I. (2021) · Springer eBooks · doi:10.1007/978-3-030-84744-9_12 · Cited by 6
Mesenchymal stem cell secretome and nanotechnology: Combining therapeutic strategies
Ferreira, A. L. P., Paris, G. C., de Azevedo, A., Cortez, E. A. C., de Carvalho, S. N., de Carvalho, L., & Thole, A. A. (2022) · Biocell · doi:10.32604/biocell.2022.019363 · Cited by 4
Hasanpour, M., Rahbarghazi, R., Nourazarian, A., Khaki‐Khatibi, F., Avcı, Ç. B., Hassanpour, M., Talebi, M., Taghavi, H., & Salimi, L. (2022) · Tissue and Cell · doi:10.1016/j.tice.2022.101808 · Cited by 5
Mesenchymal Stem Cell Secretome: A Potential Biopharmaceutical Component to Regenerative Medicine?
Araújo, B., Caridade-Silva, R., Domingues, S., Salgado, A. J., & Teixeira, F. G. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_46-1 · Cited by 4
Salkın, H., Acar, M. B., Gönen, Z. B., Başaran, K. E., & Özcan, S. (2022) · Connective Tissue Research · doi:10.1080/03008207.2022.2144733 · Cited by 6
Babaei, K., Azimi–Nezhad, M., Norollahi, S. E., Vahidi, S., & Samadani, A. A. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0948-8 · Cited by 5
Jafarinia, M., Rostami, A., Abbasi, Y., Asadian, A., Enani, H., & Jamalnia, S. (2022) · Galen Medical Journal · doi:10.31661/gmj.v11i.2529 · Cited by 5
Ogéus, T. (2024) · Open Journal of Orthopedics and Rheumatology · doi:10.17352/ojor.000049 · Cited by 4
“Central to this fi eld is the exploration of extracellular vesicles, particularly exosomes, as promising mediators of intercellular communication and tissue regeneration [1].”
Radiation‐induced sensitivity of tissue‐resident mesenchymal stem cells in the head and neck region
Spiegel, J. L., Hambrecht, M., Kohlbauer, V., Haubner, F., Ihler, F., Canis, M., Schilling, A. F., Böker, K. O., Dressel, R., Streckfuß‐Bömeke, K., et al. (2019) · Head & Neck · doi:10.1002/hed.25768 · Cited by 4
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.